This product is an ASHP Learning Center activity.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
This self-paced, online professional certificate track is designed for pharmacists who are interested in expanding their knowledge and skills in inflammatory and neurologic disease states for specialty pharmacy.
The Specialty Pharmacy Certificate is self-guided, with online learning activities that have been created for pharmacists and pharmacy technicians seeking to expand their skills in specialty pharmacy.
A learner will have completed the Specialty Pharmacy Fundamentals before beginning the Inflammatory and Neurologic Disease States Track.
The learner will take a deep dive into their selected specialty focus area with the Inflammatory and Neurologic Disease States Track. These topics include dermatology, gastroenterology, rheumatology, and neurology.
Professional Certificate Requirement
Once a learner has completed the Specialty Pharmacy Fundamentals and the Inflammatory and Neurologic Disease States Track educational curriculum, they will have the opportunity to complete the track final exam. Once the learner successfully completes the track final exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the professional certificate.
Inflammatory Conditions: The Basics
ACPE: 0204-0000-23-751-H04-P
1 contact hour
Learning Objectives:
- Categorize the management versus curative goals of therapy for inflammatory disease states.
- Summarize historical and current treatment advances for inflammatory disease states treatments.
- Assess additional clinical considerations for inflammatory disease states.
Dermatology
ACPE: 0204-0000-23-752-H01-P
2 contact hours
Learning Objectives:
- Differentiate dermatologic disease states treated with specialty medications.
- Categorize on-label versus off-label dermatologic conditions and drug therapies.
- Interpret dermatologic tools used for diagnosis.
- Evaluate vaccination requirements and recommendations.
- Summarize non-pharmacologic, non-specialty, and specialty therapies used to treat chronic dermatology conditions.
- Identify a specialty pharmacist's impact on this patient population.
Gastroenterology
ACPE: 0204-0000-23-753-H01-P
2.25 contact hours
Learning Objectives:
- Describe the prevalence and clinical presentation of inflammatory bowel disease (IBD), including subjective and objective diagnostic factors.
- Identify acute and long-term complications of IBD as well as risk factors for the development of long-term complications, including short gut syndrome.
- Recommend preventative care, nonpharmacologic, non-specialty, and/or infused treatments for patients with IBD.
- Select appropriate lab work to be ordered both prior to initiating and to monitor safety and efficacy of biologic and small molecule treatments.
- Counsel patients on the mechanism of action, dosing, administration, and common adverse drug events (ADRs) for currently available FDA-approved pharmacologic agents for IBD.
- Recommend pharmacologic regimens for patients with moderately-severely active IBD.
- Develop a therapeutic plan for patients with treatment failure, incomplete response, or loss of response to current pharmacologic regimen.
Rheumatology
ACPE: 0204-0000-23-754-H01-P
2 contact hours
Learning Objectives:
- Differentiate rheumatologic disease states treated with specialty medications.
- Summarize the impact of overlapping diseases.
- Interpret rheumatologic tools used for diagnosis and scoring.
- Evaluate vaccination requirements and recommendations.
- Summarize non-pharmacologic, non-specialty, infusion, and specialty therapies used to treat chronic rheumatologic conditions.
- Identify a specialty pharmacist's impact on this patient population.
Neurology
ACPE: 0204-0000-23-755-H01-P
2.25 contact hours
Learning Objectives:
- Describe the prevalence, clinical presentation, and pathophysiology of multiple sclerosis (MS), including subjective and objective diagnostic factors.
- Counsel patients on the mechanism of action, dosing, administration, and common adverse drug events (ADRs) for currently available FDA-approved pharmacologic agents for MS.
- Develop a therapeutic plan for treatment of MS in patients starting biologic treatments as well as in patients with treatment failure or intolerance to a current pharmacologic regimen.
- Recommend preventative care, nonpharmacologic treatments, non-specialty, and/or infused treatments for patients with neurologic disorders.
Stefanie Cisek, PharmD, BCACP
Clinical Pharmacist
Northwestern Medicine
Chicago, Illinois
Marci Saknini, PharmD, CSP
Clinical Pharmacist
Vanderbilt Specialty Pharmacy
Nashville, Tennessee
Relevant Financial Relationship Disclosure
In accordance with our accreditor's Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
- No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence definition of ineligible company. All relevant financial relationships have been mitigated prior to the CPE activity.
Methods and CE Requirements
This online activity consists of a combined total of 5 learning modules. Pharmacists are eligible to receive a total of 9.75 hours of continuing education credit by completing all 5 modules within this professional certificate track.
Participants must participate in the entire activity and complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts to claim credit and view your statement of credit within 60 days of completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
System Technical Requirements
System requirements courses and learning activities are delivered via your web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating web sites. View the minimum technical and system requirements for learning activities.